Meltz Mark A 4
4 · Kinnate Biopharma Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Meltz Mark A
COO General Counsel Treasurer
Transactions
- Tax Payment
Common Stock
2023-06-01$4.30/sh−541$2,326→ 29,218 total
Footnotes (3)
- [F1]The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of RSU's granted to the Reporting Person by the Issuer.
- [F2]Includes 20,313 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.
- [F3]Includes 2,473 shares acquired under the Issuers Employee Stock Purchase Plan in May 2023.